Exciting new opportunities for chemical intervention in disease have emerged based on a greater understanding of the molecular aspects of disease progression. Drug discovery combines the expertise of medicinal chemists required in translating the understanding of the molecular aspects of disease progression to the identification of suitable chemical entities, and the process of optimisation that ultimately leads to the discovery of new medicines.
To be admitted to the programme, applicants must have an undergraduate Honours qualification (minimum 2: 2) or equivalent in a scientific discipline, usually within chemistry, biology, pharmacy, biomedicine, or related fields. Candidates who do not meet these entry criteria but who can show relevant experience may also be considered.
For North American students a GPA of normally 2.0 and above (on a scale of 4.0), or an equivalent, is required.
For fees and funding options, please visit website to find out more
The largest destination of our graduates is enrolment in PhD studies (47%) including here at Bradford, as well as King’s College London, Cambridge, Manchester, Liverpool, Leeds, Newcastle, Portsmouth and Sheffield.
Career destinations of our graduates includes the NHS, Covance, Envigo, St James Hospital Leeds, Cyprotex, Chiltern, Perrigo, Dewsbury & District Hospital, Liverpool Institute of Translational Medicine, and Public Health England.
First Year
Core
Preclinical Models for Drug Evaluation
Case Studies in Drug Discovery
Cancer Therapeutics Research Project
Principles of Drug Discovery
Cancer Pharmacology and Regulatory Toxicology
Research Skills for Postgraduate Students
Cancer Pharmacology and Regulatory Toxicology
Research Skills for Postgraduate Students
Study a Postgraduate degree at Bradford Discover Master’s and taught courses at the University of Bradford What if this was your turning point? ...